Showing 1 - 7 results of 7 for search 'Deanna M. Santer', query time: 0.03s Refine Results
  1. 1
    The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections

    The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections by Adrian Egli, Deanna M Santer, Daire O’Shea, D Lorne Tyrrell, Michael Houghton

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense

    Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense by Steeve Boulant, Adriana Forero, Adriana Forero, Adriana Forero, Deanna M. Santer, Achille Broggi

    Published 2022-09-01
    Get full text
    Article
  3. 3
    Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis.

    Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis. by Deanna M Santer, Mang M Ma, Darren Hockman, Abdolamir Landi, D Lorne J Tyrrell, Michael Houghton

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

    Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity by Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, D. Lorne J. Tyrrell, Jordan J. Feld, Adam J. Gehring

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.

    Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells. by Deanna M Santer, Gillian E S Minty, Dominic P Golec, Julia Lu, Julia May, Afshin Namdar, Juhi Shah, Shokrollah Elahi, David Proud, Michael Joyce, D Lorne Tyrrell, Michael Houghton

    Published 2020-04-01
    Get full text
    Article
  6. 6
    A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.

    A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. by John Lok Man Law, Chao Chen, Jason Wong, Darren Hockman, Deanna M Santer, Sharon E Frey, Robert B Belshe, Takaji Wakita, Jens Bukh, Christopher T Jones, Charles M Rice, Sergio Abrignani, D Lorne Tyrrell, Michael Houghton

    Published 2013-01-01
    Get full text
    Article
  7. 7
    No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome.

    No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome. by Imke Steffen, D Lorne Tyrrell, Eleanor Stein, Leilani Montalvo, Tzong-Hae Lee, Yanchen Zhou, Kai Lu, William M Switzer, Shaohua Tang, Hongwei Jia, Darren Hockman, Deanna M Santer, Michael Logan, Amir Landi, John Law, Michael Houghton, Graham Simmons

    Published 2011-01-01
    Get full text
    Article

Search Tools: